WVE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 29.10%

Insider Buying (Last 12 Months): $27,335,440.00

Insider Selling (Last 12 Months): $4,742,204.70

Wave Life Sciences Insider Trading History Chart

Wave Life Sciences Share Price & Price History

^$13.84

▲ +0.05 (0.36%)

As of 11/5/2024 01:00 AM ET

Days: 30 | 90 | 365

625,000% Gain

From Crypto Swap Profits | Ad

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Wave Life Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/16/2024	Chris Francis	insider	Sell	208,836	$13.67	$2,854,788.12
10/16/2024	Paul Bolno	CEO	Sell	90,474	$15.00	$1,357,110.00	268,585
9/27/2024	Plc Gsk	Major Shareholder	Buy	2,791,930	$8.00	$22,335,440.00	16,775,691
9/25/2024	Kyle Moran	CFO	Sell	17,146	$9.00	$154,314.00	19,777
8/21/2024	Paul Bolno	CEO	Sell	48,366	$5.78	$279,555.48	359,059
4/3/2024	Kyle Moran	CFO	Sell	15,630	$6.17	$96,437.10	33,921
12/11/2023	Ra Capital Management, L.P.	Director	Buy	1,000,000	$5.00	$5,000,000.00	19,202,009
8/23/2023	Kyle Moran	CFO	Sell	37,062	$4.75	$176,044.50	46,120
2/16/2023	Chandra Vargeese	Insider	Sell	10,249	$4.03	$41,303.47	106,624
2/16/2023	Kyle Moran	CFO	Sell	9,729	$4.04	$39,305.16	79,751
2/16/2023	Paul Bolno	CEO	Sell	29,400	$4.04	$118,776.00	407,425
6/16/2022	Ra Capital Management, L.P.	Director	Buy	9,480,052	$2.15	$20,382,111.80	17,202,009
5/5/2022	Chandra Vargeese	Insider	Sell	16,714	$1.72	$28,748.08	111,095
5/5/2022	Kyle Moran	CFO	Sell	5,021	$1.72	$8,636.12	84,567
5/5/2022	Paul Bolno	CEO	Sell	33,501	$1.72	$57,621.72	436,825
2/16/2022	Chandra Vargeese	CTO	Sell	10,603	$2.32	$24,598.96
2/16/2022	Chris Francis	Insider	Sell	10,123	$2.31	$23,384.13
2/16/2022	Kyle Moran	CFO	Sell	9,204	$2.31	$21,261.24
2/16/2022	Paul Bolno	CEO	Sell	33,150	$2.32	$76,908.00

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Wave Life Sciences (NASDAQ:WVE)

89.73% of Wave Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Wave Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/5/2024	GSA Capital Partners LLP	63,513	$0.52M	0.0%	+14.9%	0.051%
11/2/2024	Privium Fund Management B.V.	48,834	$0.40M	0.1%	N/A	0.039%
10/30/2024	James J. Burns & Company LLC	100,111	$0.82M	0.1%	+11.2%	0.082%
10/29/2024	Emerald Advisers LLC	2,881,510	$23.63M	0.9%	+15.6%	2.353%
10/29/2024	Emerald Mutual Fund Advisers Trust	2,123,466	$17.41M	0.9%	+16.6%	1.734%
10/28/2024	US Bancorp DE	18,043	$0.15M	0.0%	+53.9%	0.015%
10/25/2024	China Universal Asset Management Co. Ltd.	23,991	$0.20M	0.0%	+66.7%	0.020%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	4,512	$37K	0.0%	+23.4%	0.004%
10/23/2024	Moody Aldrich Partners LLC	303,062	$2.49M	0.5%	+69.0%	0.247%
10/3/2024	SG Americas Securities LLC	36,563	$0.30M	0.0%	-72.7%	0.030%
8/19/2024	Point72 Asset Management L.P.	115,478	$0.58M	0.0%	-94.2%	0.094%
8/16/2024	Driehaus Capital Management LLC	908,096	$4.53M	0.0%	+62.2%	0.728%
8/15/2024	Susquehanna Fundamental Investments LLC	18,744	$94K	0.0%	-71.4%	0.015%
8/15/2024	Mackenzie Financial Corp	15,887	$79K	0.0%	+13.6%	0.013%
8/15/2024	The Manufacturers Life Insurance Company	139,790	$0.70M	0.0%	+3.6%	0.112%
8/15/2024	Millennium Management LLC	1,664,300	$8.31M	0.0%	+1.8%	1.334%
8/15/2024	Maverick Capital Ltd.	7,669,361	$38.27M	0.7%	-0.2%	6.148%
8/15/2024	AQR Capital Management LLC	33,529	$0.17M	0.0%	+26.3%	0.027%
8/15/2024	Affinity Asset Advisors LLC	375,000	$1.87M	0.2%	+30.9%	0.301%
8/14/2024	Marshall Wace LLP	62,102	$0.31M	0.0%	-80.2%	0.050%
8/14/2024	ProShare Advisors LLC	17,410	$87K	0.0%	-20.0%	0.014%
8/14/2024	Profund Advisors LLC	10,625	$53K	0.0%	N/A	0.009%
8/13/2024	M28 Capital Management LP	6,164,548	$30.76M	39.9%	-11.9%	4.942%
8/13/2024	Sei Investments Co.	26,095	$0.13M	0.0%	N/A	0.021%
8/12/2024	Hsbc Holdings PLC	21,444	$0.10M	0.0%	N/A	0.017%
8/9/2024	Primecap Management Co. CA	2,664,216	$13.29M	0.0%	-7.4%	2.175%
8/6/2024	Emerald Advisers LLC	2,493,230	$12.44M	0.5%	N/A	2.036%
8/6/2024	Emerald Mutual Fund Advisers Trust	1,820,938	$9.09M	0.5%	N/A	1.487%
8/3/2024	TD Asset Management Inc	183,946	$0.92M	0.0%	-27.0%	0.150%
8/1/2024	Rhumbline Advisers	125,834	$0.63M	0.0%	+3.4%	0.103%
7/29/2024	Principal Financial Group Inc.	14,766	$74K	0.0%	N/A	0.012%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	33,491	$0.17M	0.0%	+75.2%	0.027%
7/26/2024	Bank of New York Mellon Corp	225,402	$1.13M	0.0%	+13.9%	0.184%
7/17/2024	James J. Burns & Company LLC	90,000	$0.45M	0.1%	N/A	0.073%
7/13/2024	Kraematon Investment Advisors Inc.	19,000	$95K	0.1%	-13.6%	0.016%
7/12/2024	SG Americas Securities LLC	133,827	$0.67M	0.0%	N/A	0.109%
5/17/2024	Artal Group S.A.	4,051,400	$25M	0.6%	+34.7%	3.308%
5/17/2024	Ikarian Capital LLC	590,088	$3.64M	0.4%	N/A	0.482%
5/16/2024	Jacobs Levy Equity Management Inc.	241,860	$1.49M	0.0%	+13.9%	0.198%
5/15/2024	Bellevue Group AG	4,094,458	$25.26M	0.4%	-8.9%	3.344%
5/15/2024	Price T Rowe Associates Inc. MD	1,861,254	$11.49M	0.0%	+14.4%	1.520%
5/15/2024	M28 Capital Management LP	7,000,000	$43.19M	31.9%	-5.1%	5.723%
5/15/2024	Affinity Asset Advisors LLC	286,585	$1.77M	0.2%	N/A	0.234%
5/14/2024	Platinum Investment Management Ltd.	600,155	$3.70M	0.1%	-8.4%	0.491%
5/14/2024	American International Group Inc.	36,241	$0.22M	0.0%	+23.3%	0.030%
5/13/2024	Ameritas Investment Partners Inc.	7,334	$45K	0.0%	+50.2%	0.006%
5/10/2024	Vanguard Group Inc.	1,834,090	$11.32M	0.0%	+39.7%	1.499%
5/8/2024	ProShare Advisors LLC	21,764	$0.13M	0.0%	+35.0%	0.018%
5/7/2024	Susquehanna Fundamental Investments LLC	65,565	$0.41M	0.0%	N/A	0.054%
5/7/2024	Swiss National Bank	156,500	$0.97M	0.0%	+2.7%	0.128%
5/3/2024	GSA Capital Partners LLP	95,037	$0.59M	0.0%	N/A	0.078%
5/1/2024	Capstone Investment Advisors LLC	54,500	$0.34M	0.0%	+9.0%	0.045%
4/29/2024	China Universal Asset Management Co. Ltd.	23,473	$0.15M	0.0%	+104.9%	0.019%
3/5/2024	Wellington Management Group LLP	274,093	$1.38M	0.0%	+3.5%	0.277%
2/26/2024	Virtu Financial LLC	34,432	$0.17M	0.0%	N/A	0.035%
2/16/2024	Public Employees Retirement System of Ohio	12,600	$64K	0.0%	N/A	0.013%
2/15/2024	Birchview Capital LP	40,000	$0.20M	0.2%	N/A	0.040%
2/14/2024	Platinum Investment Management Ltd.	655,331	$3.31M	0.1%	+43.9%	0.662%
2/13/2024	Tower Research Capital LLC TRC	11,335	$57K	0.0%	+461.4%	0.011%
2/13/2024	James J. Burns & Company LLC	65,049	$0.33M	0.1%	+96.8%	0.066%
2/12/2024	Capstone Investment Advisors LLC	50,000	$0.25M	0.0%	N/A	0.050%
2/12/2024	Monashee Investment Management LLC	103,300	$0.52M	0.1%	N/A	0.104%
2/12/2024	M28 Capital Management LP	7,373,413	$37.24M	30.8%	+4.7%	7.444%
2/12/2024	TD Asset Management Inc	205,746	$1.04M	0.0%	+26.5%	0.208%
2/9/2024	Primecap Management Co. CA	3,759,408	$18.99M	0.0%	-0.6%	3.795%
2/9/2024	Oxford Asset Management LLP	10,045	$51K	0.1%	N/A	0.010%
2/9/2024	Trexquant Investment LP	32,119	$0.16M	0.0%	N/A	0.032%
2/7/2024	Teacher Retirement System of Texas	17,105	$86K	0.0%	N/A	0.017%
2/6/2024	Swiss National Bank	152,400	$0.77M	0.0%	N/A	0.154%
2/6/2024	a16z Perennial Management L.P.	77,619	$0.39M	0.1%	N/A	0.078%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	32,250	$0.16M	0.0%	+1,512.5%	0.033%
1/30/2024	Strs Ohio	75,800	$0.38M	0.0%	N/A	0.077%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	35,523	$0.18M	0.0%	-59.0%	0.036%
1/24/2024	Arizona State Retirement System	17,943	$91K	0.0%	N/A	0.018%
1/24/2024	China Universal Asset Management Co. Ltd.	11,456	$58K	0.0%	+351.7%	0.012%
1/12/2024	SG Americas Securities LLC	34,562	$0.18M	0.0%	+33.6%	0.035%
1/12/2024	Kraematon Investment Advisors Inc.	47,000	$0.24M	0.3%	N/A	0.047%
12/1/2023	Wellington Management Group LLP	264,885	$1.52M	0.0%	+4.3%	0.267%
11/15/2023	Kynam Capital Management LP	3,932,082	$22.61M	3.7%	+0.2%	3.970%
11/15/2023	Laurion Capital Management LP	871,500	$5.01M	0.0%	+5.1%	0.880%
11/15/2023	Adage Capital Partners GP L.L.C.	3,787,730	$21.78M	0.0%	-18.0%	3.824%
11/14/2023	683 Capital Management LLC	5,850,000	$33.64M	2.6%	-3.0%	5.906%
11/14/2023	Newtyn Management LLC	510,000	$2.93M	0.7%	+2.0%	0.515%
11/14/2023	Primecap Management Co. CA	3,780,508	$21.74M	0.0%	-0.8%	3.817%
11/13/2023	M28 Capital Management LP	7,044,500	$40.51M	46.4%	-0.1%	7.112%
11/13/2023	FMR LLC	660,425	$3.80M	0.0%	-14.7%	0.667%
11/7/2023	New York State Common Retirement Fund	7,923	$46K	0.0%	-67.7%	0.008%
11/7/2023	James J. Burns & Company LLC	33,049	$0.19M	0.1%	+10.2%	0.033%
11/7/2023	Jump Financial LLC	23,545	$0.14M	0.0%	N/A	0.024%
10/27/2023	TD Asset Management Inc	162,692	$0.94M	0.0%	N/A	0.164%
10/26/2023	Clear Harbor Asset Management LLC	14,000	$80K	0.0%	-60.8%	0.014%
10/26/2023	Chicago Partners Investment Group LLC	11,136	$60K	0.0%	-40.8%	0.011%
10/13/2023	SG Americas Securities LLC	25,868	$0.15M	0.0%	N/A	0.026%
9/21/2023	Barclays PLC	18,837	$69K	0.0%	-39.9%	0.019%
8/15/2023	Kynam Capital Management LP	3,924,602	$14.29M	2.0%	+3.1%	3.965%
8/14/2023	683 Capital Management LLC	6,031,000	$21.95M	1.6%	+0.5%	6.093%
8/11/2023	M28 Capital Management LP	7,050,000	$25.66M	33.9%	+1.4%	7.123%
8/11/2023	Artal Group S.A.	2,870,523	$10.45M	0.3%	-4.3%	2.900%
8/8/2023	Chicago Partners Investment Group LLC	18,799	$82K	0.0%	-33.3%	0.019%
8/4/2023	American International Group Inc.	28,459	$0.10M	0.0%	N/A	0.029%

Data available starting January 2016

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

Today's Range

Now: $13.84

$13.42

$13.91

50 Day Range

MA: $9.20

$5.12

$15.31

52 Week Range

Now: $13.84

$3.50

$15.92

Volume

1,002,557 shs

Average Volume

1,099,906 shs

Market Capitalization

$1.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Wave Life Sciences?: Wave Life Sciences' top insider shareholders include:
Ra Capital Management, LP (Director)
Plc Gsk (Major Shareholder)
Paul Bolno (CEO)
Chandra Vargeese (Insider)
Kyle Moran (CFO)
Chris Francis (Insider)
Learn More about top insider investors at Wave Life Sciences.
Who are the major institutional investors of Wave Life Sciences?: Wave Life Sciences' top institutional shareholders include:
Emerald Advisers LLC — 2.35%
Emerald Mutual Fund Advisers Trust — 1.73%
Moody Aldrich Partners LLC — 0.25%
James J. Burns & Company LLC — 0.08%
GSA Capital Partners LLP — 0.05%
Privium Fund Management B.V. — 0.04%
Learn More about top institutional investors of Wave Life Sciences stock.
Which major investors are selling Wave Life Sciences stock?: In the previous quarter, WVE stock was sold by these institutional investors:
SG Americas Securities LLC
During the previous year, company insiders that have sold Wave Life Sciences company stock include:
Ra Capital Management, LP (Director)
Plc Gsk (Major Shareholder)
Paul Bolno (CEO)
Learn More investors selling Wave Life Sciences stock.
Which major investors are buying Wave Life Sciences stock?: Within the previous quarter, WVE stock was bought by institutional investors including:
Emerald Advisers LLC
Emerald Mutual Fund Advisers Trust
Moody Aldrich Partners LLC
Privium Fund Management B.V.
James J. Burns & Company LLC
China Universal Asset Management Co. Ltd.
GSA Capital Partners LLP
US Bancorp DE
Within the previous year, these company insiders have bought Wave Life Sciences stock:
Ra Capital Management, LP (Director)
Plc Gsk (Major Shareholder)
Learn More investors buying Wave Life Sciences stock.